• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

许多与蛋白结合的溶质被肾脏高效清除。

Numerous protein-bound solutes are cleared by the kidney with high efficiency.

机构信息

Department of Medicine, VA Palo Alto HCS, Palo Alto, California 94303, USA.

出版信息

Kidney Int. 2013 Sep;84(3):585-90. doi: 10.1038/ki.2013.154. Epub 2013 May 1.

DOI:10.1038/ki.2013.154
PMID:23636170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3758437/
Abstract

The kidney clears numerous solutes from the plasma; however, retention of these solutes causes uremic illness when the kidneys fail. We know remarkably little about which retained solutes are toxic and this limits our ability to improve dialysis therapies. To explore this, we employed untargeted mass spectrometry to identify solutes that are efficiently cleared by the kidney. High-resolution mass spectrometry detected 1808 features in the urine and plasma ultrafiltrate of 5 individuals with normal renal function. The estimated clearance rates of 1082 peaks were greater than the creatinine clearance indicating tubular secretion. Further analysis identified 90 features representing solutes with estimated clearance rates greater than the renal plasma flow. Quantitative mass spectrometry with stable isotope dilution confirmed that efficient clearance of these solutes is made possible by the combination of binding to plasma proteins and tubular secretion. Tandem mass spectrometry established the chemical identity of 13 solutes including hippuric acid, indoxyl sulfate, and p-cresol sulfate. These 13 efficiently cleared solutes were found to accumulate in the plasma of hemodialysis patients, with free levels rising to more than 20-fold normal for all but two of them. Thus, further analysis of solutes efficiently cleared by secretion in the native kidney may provide a potential route to the identification of uremic toxins.

摘要

肾脏从血浆中清除许多溶质;然而,当肾脏衰竭时,这些溶质的潴留会导致尿毒症。我们对哪些潴留的溶质是有毒的知之甚少,这限制了我们改善透析疗法的能力。为了探索这一点,我们采用非靶向质谱法来鉴定被肾脏有效清除的溶质。高分辨率质谱法在 5 名肾功能正常的个体的尿液和血浆超滤液中检测到 1808 个特征。1082 个峰的估计清除率大于肌酐清除率,表明存在肾小管分泌。进一步分析确定了 90 个特征,代表估计清除率大于肾血浆流量的溶质。用稳定同位素稀释的定量质谱法证实,这些溶质的有效清除是通过与血浆蛋白结合和肾小管分泌的结合来实现的。串联质谱法确定了 13 种溶质的化学结构,包括马尿酸、吲哚硫酸和对甲酚硫酸。这些 13 种被有效清除的溶质在血液透析患者的血浆中积累,除了两种溶质之外,所有溶质的游离水平上升到正常水平的 20 倍以上。因此,对在天然肾脏中通过分泌有效清除的溶质进行进一步分析,可能为鉴定尿毒症毒素提供一条潜在途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e6/3758437/d25b33597db7/nihms-463903-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e6/3758437/d25b33597db7/nihms-463903-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e6/3758437/d25b33597db7/nihms-463903-f0001.jpg

相似文献

1
Numerous protein-bound solutes are cleared by the kidney with high efficiency.许多与蛋白结合的溶质被肾脏高效清除。
Kidney Int. 2013 Sep;84(3):585-90. doi: 10.1038/ki.2013.154. Epub 2013 May 1.
2
Association Between Kidney Clearance of Secretory Solutes and Cardiovascular Events: The Chronic Renal Insufficiency Cohort (CRIC) Study.分泌溶质的肾清除率与心血管事件的关系:慢性肾功能不全队列(CRIC)研究。
Am J Kidney Dis. 2021 Aug;78(2):226-235.e1. doi: 10.1053/j.ajkd.2020.12.005. Epub 2021 Jan 7.
3
Protein-bound molecules: a large family with a bad character.蛋白质结合分子:一个具有不良特性的大家族。
Semin Nephrol. 2014 Mar;34(2):106-17. doi: 10.1016/j.semnephrol.2014.02.004. Epub 2014 Feb 18.
4
Exploring binding characteristics and the related competition of different protein-bound uremic toxins.探索不同蛋白结合型尿毒症毒素的结合特性及相关竞争性。
Biochimie. 2017 Aug;139:20-26. doi: 10.1016/j.biochi.2017.05.010. Epub 2017 May 17.
5
Contribution of residual function to removal of protein-bound solutes in hemodialysis.残余肾功能对血液透析清除蛋白结合溶质的作用。
Clin J Am Soc Nephrol. 2011 Feb;6(2):290-6. doi: 10.2215/CJN.06100710. Epub 2010 Oct 28.
6
Prominent accumulation in hemodialysis patients of solutes normally cleared by tubular secretion.在血液透析患者中,通常通过肾小管分泌清除的溶质明显蓄积。
J Am Soc Nephrol. 2014 Mar;25(3):615-22. doi: 10.1681/ASN.2013060597. Epub 2013 Nov 14.
7
Uremic solutes from colon microbes.肠道微生物来源的尿毒症溶质。
Kidney Int. 2012 May;81(10):949-954. doi: 10.1038/ki.2011.504. Epub 2012 Feb 8.
8
Impaired Tubular Secretion of Organic Solutes in Advanced Chronic Kidney Disease.晚期慢性肾脏病中有机溶质的肾小管分泌受损。
J Am Soc Nephrol. 2021 Nov;32(11):2877-2884. doi: 10.1681/ASN.2021030336. Epub 2021 Aug 18.
9
Removal of the protein-bound solutes indican and p-cresol sulfate by peritoneal dialysis.通过腹膜透析清除与蛋白质结合的溶质吲哚硫酸盐和对甲酚硫酸盐。
Clin J Am Soc Nephrol. 2008 Jan;3(1):85-90. doi: 10.2215/CJN.02570607. Epub 2007 Nov 28.
10
Diurnal and Long-term Variation in Plasma Concentrations and Renal Clearances of Circulating Markers of Kidney Proximal Tubular Secretion.肾近端小管分泌循环标志物的血浆浓度及肾清除率的昼夜变化和长期变化
Clin Chem. 2017 Apr;63(4):915-923. doi: 10.1373/clinchem.2016.260117. Epub 2017 Feb 10.

引用本文的文献

1
Association of Phenylacetylglutamine and Cognitive Impairment in CKD.慢性肾脏病中苯乙酰谷氨酰胺与认知障碍的关联
Kidney Int Rep. 2025 May 29;10(8):2720-2731. doi: 10.1016/j.ekir.2025.05.037. eCollection 2025 Aug.
2
Loop diuretics in anuric hemodialysis patients for the clearance of protein-bound uremic toxins.在无尿血液透析患者中使用袢利尿剂清除蛋白结合型尿毒症毒素。
Clin Kidney J. 2025 Jun 14;18(7):sfaf195. doi: 10.1093/ckj/sfaf195. eCollection 2025 Jul.
3
Klotho Suppresses Indoxyl Sulfate-Mediated Apoptosis in Human Kidney Proximal Tubular (HK-2) Cells through Modulating the AKT/Nrf2 Mechanism.

本文引用的文献

1
Annotation of the human adult urinary metabolome and metabolite identification using ultra high performance liquid chromatography coupled to a linear quadrupole ion trap-Orbitrap mass spectrometer.采用超高效液相色谱-线性四极杆轨道阱质谱联用技术对人成年尿液代谢组学进行注释及代谢物鉴定。
Anal Chem. 2012 Aug 7;84(15):6429-37. doi: 10.1021/ac300829f. Epub 2012 Jul 17.
2
Normal and pathologic concentrations of uremic toxins.正常和病态的尿毒症毒素浓度。
J Am Soc Nephrol. 2012 Jul;23(7):1258-70. doi: 10.1681/ASN.2011121175. Epub 2012 May 24.
3
Evaluation of coupling reversed phase, aqueous normal phase, and hydrophilic interaction liquid chromatography with Orbitrap mass spectrometry for metabolomic studies of human urine.
α-klotho通过调节AKT/Nrf2机制抑制硫酸吲哚酚介导的人肾近端小管(HK-2)细胞凋亡。
ACS Omega. 2025 Jun 3;10(23):24018-24029. doi: 10.1021/acsomega.4c08038. eCollection 2025 Jun 17.
4
Release of apoptosis inhibitor of macrophage (AIM) from pentameric IgM in serum predicts prognosis after hemodialysis initiation.血清中五聚体IgM释放巨噬细胞凋亡抑制因子(AIM)可预测血液透析开始后的预后。
Commun Med (Lond). 2025 Jan 11;5(1):15. doi: 10.1038/s43856-025-00735-8.
5
Impaired renal transporter gene expression and uremic toxin excretion as aging hallmarks in cats with naturally occurring chronic kidney disease.肾转运蛋白基因表达受损和尿毒症毒素排泄作为自然发生的慢性肾病猫衰老的标志。
Aging (Albany NY). 2024 Dec 20;16(22):13588-13607. doi: 10.18632/aging.206176.
6
Plasma Metabolite Profiles Between In-Center Daytime Extended-Hours and Conventional Hemodialysis.中心日间延长时间血液透析与传统血液透析之间的血浆代谢物谱
Kidney360. 2025 Mar 1;6(3):420-431. doi: 10.34067/KID.0000000675. Epub 2024 Dec 9.
7
Structure-based discovery of a new type of scaffold compound as binding competitors for protein-bound Uremic Toxins.基于结构的新型支架化合物的发现,作为与蛋白结合型尿毒症毒素结合的竞争抑制剂。
Sci Rep. 2024 Nov 15;14(1):28152. doi: 10.1038/s41598-024-78766-9.
8
Reducing the levels of indoxyl sulfate in patients undergoing dialysis: a promising approach to managing inflammation and the redox state of human serum albumin.降低透析患者的硫酸吲哚酚水平:一种有前途的方法,可用于管理炎症和人血清白蛋白的氧化还原状态。
J Med Life. 2024 Aug;17(8):791-799. doi: 10.25122/jml-2023-0538.
9
Physiological principles underlying the kidney targeting of renal nanomedicines.肾脏纳米药物靶向肾脏的生理原理。
Nat Rev Nephrol. 2024 Jun;20(6):354-370. doi: 10.1038/s41581-024-00819-z. Epub 2024 Feb 26.
10
Role of the Gut Bacteria-Derived Metabolite Phenylacetylglutamine in Health and Diseases.肠道细菌衍生代谢物苯乙酰谷氨酰胺在健康与疾病中的作用
ACS Omega. 2024 Jan 8;9(3):3164-3172. doi: 10.1021/acsomega.3c08184. eCollection 2024 Jan 23.
评估反相、水相正相和亲水相互作用液相色谱与轨道阱质谱联用在人尿液代谢组学研究中的应用。
Anal Chem. 2012 Feb 21;84(4):1994-2001. doi: 10.1021/ac2030738. Epub 2012 Feb 1.
4
Uremic solutes from colon microbes.肠道微生物来源的尿毒症溶质。
Kidney Int. 2012 May;81(10):949-954. doi: 10.1038/ki.2011.504. Epub 2012 Feb 8.
5
Dialysis cannot be dosed.透析无法定量。
Semin Dial. 2011 Sep-Oct;24(5):471-9. doi: 10.1111/j.1525-139X.2011.00979.x. Epub 2011 Sep 19.
6
Colonic contribution to uremic solutes.肠道对尿毒症溶质的贡献。
J Am Soc Nephrol. 2011 Sep;22(9):1769-76. doi: 10.1681/ASN.2010121220. Epub 2011 Jul 22.
7
Ion-pairing reversed-phase liquid chromatography fractionation in combination with isotope labeling reversed-phase liquid chromatography-mass spectrometry for comprehensive metabolome profiling.离子对反相液相色谱分离与同位素标记反相液相色谱-质谱联用的综合代谢组学分析。
J Chromatogr A. 2011 Jun 10;1218(23):3689-94. doi: 10.1016/j.chroma.2011.04.024. Epub 2011 Apr 16.
8
Untargeted metabolomics identifies enterobiome metabolites and putative uremic toxins as substrates of organic anion transporter 1 (Oat1).非靶向代谢组学鉴定肠菌代谢物和潜在尿毒症毒素为有机阴离子转运蛋白 1(Oat1)的底物。
J Proteome Res. 2011 Jun 3;10(6):2842-51. doi: 10.1021/pr200093w. Epub 2011 Apr 22.
9
The human serum metabolome.人类血清代谢组。
PLoS One. 2011 Feb 16;6(2):e16957. doi: 10.1371/journal.pone.0016957.
10
Update of uremic toxin research by mass spectrometry.采用质谱技术对尿毒症毒素的研究进展更新。
Mass Spectrom Rev. 2011 May-Jun;30(3):510-21. doi: 10.1002/mas.20323. Epub 2011 Feb 16.